Amarin Corp Plcuk (AMRN) Accumulated Expenses (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Accumulated Expenses of $131.5 million for Q1 2026, up 12.63% year-over-year from $116.7 million in Q1 2025, and down 11.81% quarter-over-quarter from $149.1 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Accumulated Expenses (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Accumulated Expenses data on file, last reported at $131.5 million in Q1 2026.

  • Accumulated Expenses for Q1 2026 came in at $131.5 million, up 12.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $131.5 million (up 12.63% YoY), and the FY2025 annual result was $149.1 million, up 870.6% from the prior year.
  • Accumulated Expenses fell to $131.5 million in Q1 2026 per AMRN's latest filing, from $149.1 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $243.1 million in Q2 2022 and troughed at $3.6 million in Q4 2023.
  • A 5-year average of $145.1 million and a median of $154.4 million in 2024 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2023 and 2025: Accumulated Expenses sank 82.33% in 2023, then surged 870.6% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $20.3 million in 2022, then tumbled by 82.33% to $3.6 million in 2023, then jumped by 328.27% to $15.4 million in 2024, then surged by 870.6% to $149.1 million in 2025, then slipped by 11.81% to $131.5 million in 2026.
  • Business Quant data shows AMRN's Accumulated Expenses at $131.5 million in Q1 2026, $149.1 million in Q4 2025, and $145.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 131.49 Mn
Dec 31, 2025 149.10 Mn
Sep 30, 2025 145.52 Mn
Jun 30, 2025 141.24 Mn
Mar 31, 2025 116.75 Mn
Dec 31, 2024 15.36 Mn
Sep 30, 2024 161.05 Mn
Jun 30, 2024 176.16 Mn
Mar 31, 2024 154.44 Mn
Dec 31, 2023 3.59 Mn
Sep 30, 2023 211.30 Mn
Jun 30, 2023 214.60 Mn
Mar 31, 2023 183.26 Mn
Dec 31, 2022 20.30 Mn
Sep 30, 2022 192.00 Mn
Jun 30, 2022 243.06 Mn
Mar 31, 2022 207.62 Mn
Dec 31, 2021 3.56 Mn
Sep 30, 2021 289.68 Mn
Jun 30, 2021 226.55 Mn